Metabolic abnormalities in 2612 patients with nephrolithiasis;Alteraciones metabolicas en 2612 pacientes conlitiasis renal

Medicina

Volumn 59, Issue 5 I, 1999, Pages 417-422

  Del Valle, Elisa ^a,b   Spivacow, Rodolfo ^a   Zanchetta, Jose R ^a  

^a Instituto de Investigaciones Metabolicas   (Argentina)

^b NONE   (Argentina)

Author keywords

Epidemiology; Metabolic abnormalities; Nephrolithiasis

Indexed keywords

CALCIUM; URIC ACID;

ADULT; ARTICLE; FEMALE; HUMAN; MALE; METABOLISM; NEPHROLITHIASIS; SEX DIFFERENCE; URINE;

ADULT; CALCIUM; FEMALE; HUMANS; KIDNEY CALCULI; MALE; SEX FACTORS; URIC ACID;

EID: 0041525974     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Preminger GM: The metabolic evaluation of patients with recurrent nephrolithiasis: a review of comprehensive and simplified approaches. J Urol 1989; 141: 760-3.
2. th Lati-namerican Congress of Nephrology. Buenos Aires, mayo 2.6, 1999, p. 279.
3. Pyrah LN. Clinical Picture of Renal and Ureteric calculus. In: Renal calculus. Berlin: Springer-Verlag 1979; p 185-209.
4. Ljunghall S, Hedstrand H. Epidemiology of renal stone in middle-aged population. Acta Med Scand 1975; 197: 439-45.
5. Marshall V, White RH, De Saintonge MG, Tressider GC, Blandy JP. The natural history of renal and ureteric calculi. Br J Urol 1975; 47: 117-24.
6. Stapleton F:B, Roi III S, Noc HN, Jerkins GI. Hypercalciuria in children with hematuria. N Engl J Med 1984; 310: 1345-8.
7. Mallone JI, Lowitt S, Duncan JA, Shah SC. Hematuria e hipercalciuria en niños con diabetes mellitus. Pediatrics (ed. española) 1987; 23 (5): 80-2.
8. Pak CYC, Britton F, Peterson R, et al. Ambulatory evaluation of nephrolithiasis: Classification, clinical presentation and diagnostic criteria. Am J Med 1980; 69: 19-30.
9. Dumolin G, Haton D, Wolf JP, et al. Étude comparée de la calciurie, de l'oxalurie et de l'uricurie dans la lithiase oxalocalciquo. Nephrologie 1984; 5: 189-91.
10. Levy FL, Adams-Huet B, Pak CYC. Ambulatory Evaluation of Nephrolithiasis: An Update of a 1980 Protocol. Am J Med 1995; 98: 50-9.
11. Mocellini Ituralde JA, Zanchetta JR: Litiasis renal: actualización y experiencia en el estudio metabólico y en el tratamlento mécico quirúrgico. Arch Españoles Urol 1982; 35: 89-102.
12. Snedecor GW and Cochran WG. Statistical methods. VI Ed. Iowa State University Press; Ames 1969.
13. Lagergren C Biophysical investigations of urinary calculi. An X-ray crystallographic and microradiographic study. Acta Radiol (Stockl) suppl 1956; 133: 1-71.
14. El llI AS. Composition of urinary calculi from normocalciuric patients in Egipt. J Coll Sci King Saud Univ 1984; 15 (2): 565-71.
15. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327: 1142-52.
16. Robertson WG, Peacock M, Hodgkinson A. Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976. J Chronic Dis 1979, 32: 468-76.
17. Andersen DA. Historical and geographical differences in the pattern of incidence of urinary stones considered in relation to possible aetiological factors. In: Proc. Renal Stone Res. Symp., Leeds, Hodgkinson A; Nordin, B.E.C. (eds). London, Churchill 1969; 7-31.
18. Andersen DA. Enviromental factors in the etiology of urolithiasis. In: Urinary calculi. Cifuentes Delatte L, Rapado A, Hodgkinson A (eds) Basel Kargel; 1972 p. 130-5.
19. Pyrah LN. Epidemiology of urolithiasis. In: Renal calculus. New York Springer-Verlag; 1979, 3-17.
20. del Valle EE, Spivacow FR, Bogado C, Zanchetta JR. Recurrencia de nefrolitiasis en pacientes con alteraciones metabólicas bajo tratamiento. Rev Nefrol Diálisis Transpl 1990; S: S58.
21. Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces Calcium oxalate calculous recurrence but magnesium hydroxide does. J Urol 1988; 139: 679-84.
22. Pak CYC, Fuller C. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Ann Int Med 1986; 104: 33-7.
23. Weisinger JR, Bellorín-Font E. Experiencia Latino-Americana em Litíase Renal. Venezuela. En: Calculose Renal. Fisiopatologia, Diagnóstico, Tratamiento. N Schor, I Pfeferman Heilberg (eds), São Paulo; Sarvier 1995; 354-9.
24. Massari PU, Garay G, Holtz RM. Experiencia Latinoa-Americana em Litíase Renal. Córdoba. En: Calculose Renal. Fisiopatologia, Diagnostico Tratamiento. N Schor, I Pfeferman Heilberg (eds), São Paulo; Sarvier 1995; 342-6.
25. Consensus Conference - Prevention and treatment of Kidney Stones. JAMA 1988; 260: 977-81.
26. Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer EB. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 1984; 311:73-80.
27. Breslau NA, Preminger GM, Adams BV, Otey J, Pak CYC. Use of ketoconazole to probe the pathogenetic importance of 1,25 dihydoxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 1992; 75: 1446-52.
28. Bataille P, Achard JM, Fournier A, et al. Diet, vitamin D and vertebral mineral density in hipercalciuric calcium stones formers. Kidney Int. 1991; 39: 1193-205.
29. pacifici R, Rothstein M, Rifas L, et al. Increased monocityte interleukin-I activity and decreased vertebral bone density in patients with fasting hipercalciuria. J Clin Endocrinol Metab 1990; 71: 138-45.
30. Weisinger JR, Alozo E, Bellorin-Font E, et al. Possible role of citokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int. 1996, 46: 244-50.
31. Coe FL, Parks JH. Nephrolithiasis: Pathogenesis and treatment. New York Year Book Medical Publishers, 1988.
32. Zanchetta JR, Rodriguez F, Negri AL, del Valle EE, Spivacow FR. Bone Mineral Density in Patients with Hypercalciuric Nephrolithiasis. Nephron, 1996; 73: 557-60.
33. Breslau NA, Sakhaee D. Pathophysiology of nonhypercalciuric causes stone. In: Renal stone disease. Pathogenesis, Prevention and Treatment. Ed. by CYC Pak. Dallas Martinus Nijhoff 1987; p. 47-84.
34. Heilberg IP, Teixeira SH, Novoa CG, et al. The Brazilian Multicentric study of Nephrolithiasis (Multilit). In Urolithiasis 1996. Edited by CYC Pak, MI Resnick, GM Preminger Dallas, Texas, USA p 498-9.
35. FUSS M, Pepersack T, Corvilain J, et al. Infrequency of Primary Hyperparathyroidism in Renal Stone Formers. Br J Urol 1988; 62: 4-6.
36. Sedlack JD, Kenkel J, Reid Czarapata BJ, Paul MG, Pahira JJ, Lee TC. Primary Hyperparathyroidism in patients with renal stones. Surgery 1990; 171: 206.8.
37. Mintz DH, Canary JJ, Carreon G, Kyle LH. Hyperuricemia in Hyperparathyroidism N Engl J Med 1961; 265: 112-5.
38. Thier SO, Halperin EC: Cystinuria. In: Coe FL, ed. Nephrolithiasis. New York: Churchill Livingstone 1989, 208-30.
39. Spivacow FR, del Valle EE, Zanchetta JR. Changes in metabolic alterations in nephrolithiasic patients. In: Urolithiasis 1996. Edited by CYC Pak, MI Resnick, GM Preminger; Dallas. 478-9.